Guideline on the design and conduct of cystic fibrosis clinical trials: The European Cystic Fibrosis Society-Clinical Trials Network (ECFS-CTN)
Journal of Cystic Fibrosis , Volume 10 - Issue SUPPL. 2
We describe the rationale for disease specific research networks in general as well as the aims and function of the European Cystic Fibrosis Society-Clinical Trials Network (ECFS-CTN) specifically. The ECFS-CTN was founded in 2009 with the aim of improving the quality and quantity of clinical research in the area of cystic fibrosis (CF) in Europe. A network of 18 clinical trial sites in 8 European countries was established according to uniform state-of-the-art quality criteria. To support the ECFS-CTN in the acquisition, planning and conduct of clinical trials, the network is equipped with a coordinating centre, steering and executive committees, and committees for protocol review, standardization, training and networking as well as a data safety monitoring board. A strong partnership with European CF patient parent organizations aims to increase awareness of the need for efficient clinical research and the participation of patients in clinical trials.
|Clinical trials, Cystic fibrosis, Research network|
|Journal of Cystic Fibrosis|
|Organisation||Erasmus MC: University Medical Center Rotterdam|
de Boeck, K, Bulteel, V, Tiddens, H.A.W.M, Wagner, T.O.F, Fajac, I, Conway, S, … Elborn, S. (2011). Guideline on the design and conduct of cystic fibrosis clinical trials: The European Cystic Fibrosis Society-Clinical Trials Network (ECFS-CTN). Journal of Cystic Fibrosis, 10(SUPPL. 2). doi:10.1016/S1569-1993(11)60010-6